Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pathology & Lab Medicine

According to Reuters, GlaxoSmithKline’s experimental Ebola vaccine will be moving to the second phase of its trial and expanding to several additional countries in February 2015. Currently undergoing Phase I trials in the U.S., Switzerland, Britain...
Reuters reports that an Ebola vaccine trial has been put on hiatus after four patients alleged that they were experiencing joint pains. The vaccine, developed by Merck and NewLink has been tested on fifty nine volunteers to date. Trials on the...
The CDC has issued an advisory to physicians saying the flu vaccine may not be as effective in deterring the current strain of influenza due to recent mutations in the virus, CNN Health reports. 52 percent of the 85 virus samples that were analyzed by...